- Tempest Therapeutics Inc To Discuss Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma Call TranscriptOct 11, 2023
- Tempest Therapeutics Inc at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Tempest Therapeutics Inc Annual Shareholders Meeting TranscriptJun 15, 2023
- Tempest Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Tempest Therapeutics Inc To Discuss Phase 1b/2 Combination Study of TPST-1120 in First-Line HCC Data Call TranscriptApr 28, 2023
- Tempest Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2022
- Tempest Therapeutics Inc Annual Shareholders Meeting TranscriptJun 17, 2022
- Tempest Therapeutics Inc At ASCO Call TranscriptJun 05, 2022
- Millendo Therapeutics Inc And Tempest Therapeutics Inc Merger - M&A Call TranscriptMar 29, 2021
Millendo Therapeutics Inc And Tempest Therapeutics Inc Merger - M&A Call Transcript
Good afternoon, and thank you all for joining the Tempest Therapeutics and Millendo Therapeutics call. (Operator Instructions) As a remainder, today's conference call is being recorded. (Operator Instructions) I would now like to turn the call over to Louis Arcudi, CEO of Millendo. Please go ahead.
Good morning. Thank you, John, for that, and thank you for joining us today. Joining me on the call today is Tom Hoover from my team and also Tom Dubensky and Steve Brady from the Tempest team. I'm very excited to announce that, following an extensive and thorough review of our strategic alternatives, Millendo and Tempest have agreed to merge. Focusing on advancing Tempest's potential first-in-class oncology pipeline of small molecule therapeutics and the potential to address a wide range of tumors. So if we look at Slide 2, I have to do my legal public announcement, you will see that and you will be reminded that our discussion today will contain forward-looking statements that are subject
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)